An electrophysiology platform that enables robust, scalable and long-term intracellular recording of cardiomyocytes

一个电生理学平台，能够对心肌细胞进行稳健、可扩展和长期的细胞内记录

基本信息

批准号：
10641918
负责人：
Bianxiao Cui
金额：
$ 58.86万
依托单位：
STANFORD UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-07-01 至 2026-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10641918
关键词：
3-Dimensional Academia Action Potentials Adopted Affect Amplifiers Biomedical Research Cardiac Cardiac Myocytes Cardiotoxicity Cell membrane Cells Chemistry Chronic Communities Coupled Custom Data Detection Development Diagnosis Drug Screening Electrodes Electrophysiology (science)Electroporation Funding Opportunities Goals Heart Heart Atrium Human In Situ Incubators Industrialization Industry Ion Channel Manuals Measurement Mediating Membrane Methods Monitor Nature Neurons Nodal Organoids Patch-Clamp Techniques Performance Pharmaceutical Preparations Pharmacologic Substance Physiologic pulse Physiological Process Relaxation Research Research Personnel Risk System Techniques Technology Time Translating Translations Ventricular design drug mechanism extracellular fabrication flexibility frontier heart function human pluripotent stem cell improved industry partner instrument interest miniaturize minimally invasive monolayer nanoelectrode array patch clamp pre-clinical screening solid state stem cell technology stem cells three dimensional structure tool usability voltage

项目摘要

PROJECT SUMMARY/ABSTRACT: Action potentials are temporal changes of the electrical voltage across the cell membrane, which are crucial for the physiological function of excitable cells such as neurons and cardiomyocytes. In the human heart, cardiac action potentials coordinate the synchronous contraction and relaxation of billions of cardiomyocytes. The waveforms of intracellular action potentials reflect the coordination of a multitude of ion channels, some of which are affected by pharmaceutical drugs to collectively contribute toward proarrhythmic risks. The waveforms of intracellular action potentials also reflect the subtype such as atrial-, ventricular-, or nodal-like cardiomyocytes, or their maturation status. Measurements of intracellular action potentials are mostly performed by the patch clamp technique, which is accurate but invasive, one cell at a time, laborious, and requires specialized expertise. Due to its low throughput and invasive nature, patch clamp is not suitable for drug screening or functional characterization of human pluripotent stem cell derived cardiomyocytes. In the last decade, vertically-aligned and solid-state nanoelectrode arrays (NEAs) have emerged as promising tools with the potential of achieving parallelizable and minimally invasive cardiac AP recording from monolayers of stem-cell-derived cardiomyocytes. However, despite the significant progress and the strong interest, the NEA technology has largely been confined to research groups that develop the technologies, instead of being broadly adopted by the research community. We identified several critical challenges that have hindered such effort. In this proposal, through the partnership between an academic lab and a startup company, we aim to overcome these challenges and develop a robust electrophysiological tool that enables reliable, scalable, and long-term intracellular recording of cardiomyocytes. The goal of this proposal aims to transition the NEA technology from a demonstration of possibility to a status useful to end-users.

项目概要/摘要：动作电位是跨细胞膜的电压的时间变化，这对于神经元和心肌细胞等可兴奋细胞的生理功能。在人的心脏中，心动作电位协调数十亿心肌细胞的同步收缩和舒张。这细胞内动作电位的波形反映了多种离子通道的协调，其中一些离子通道受药物影响共同导致心律失常风险。的波形细胞内动作电位还反映了心房、心室或结节样心肌细胞的亚型，或他们的成熟状态。细胞内动作电位的测量主要通过贴片进行钳夹技术准确但具有侵入性，一次一个细胞，费力且需要专业知识。由于其低通量和侵入性，膜片钳不适合药物筛选或功能人多能干细胞来源的心肌细胞的表征。在过去的十年中，垂直排列的固态纳米电极阵列（NEA）已经成为有前途的具有从单层实现可并行和微创心脏 AP 记录潜力的工具干细胞衍生的心肌细胞。然而，尽管取得了重大进展并且引起了强烈兴趣，国家能源局技术在很大程度上仅限于开发技术的研究小组，而不是广泛应用被研究界采纳。我们发现了阻碍此类努力的几个关键挑战。在这项提案，通过学术实验室和初创公司之间的合作，我们的目标是克服这些挑战并开发出一种强大的电生理学工具，能够实现可靠、可扩展和长期的心肌细胞的细胞内记录。该提案的目标是将 NEA 技术从证明对最终用户有用的状态的可能性。